Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Prevention of nosocomial Staphylococcus aureus infections after rapid detection and eradication of S. aureus carriage in patients at risk: a randomised placebo controlled multi-center trial.

Trial Profile

Prevention of nosocomial Staphylococcus aureus infections after rapid detection and eradication of S. aureus carriage in patients at risk: a randomised placebo controlled multi-center trial.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Oct 2010

At a glance

  • Drugs Chlorhexidine (Primary) ; Mupirocin (Primary)
  • Indications Nosocomial infections; Staphylococcal infections
  • Focus Therapeutic Use
  • Acronyms STEP
  • Most Recent Events

    • 15 Sep 2010 Primary endpoint results presented at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy
    • 16 Jan 2010 Status changed from planning to completed.
    • 07 Jan 2010 Results published in the New England Journal of Medicine.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top